Market closed
Landec/$LFCR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Landec
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
Ticker
$LFCR
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
524
Website
Landec Metrics
BasicAdvanced
$279M
Market cap
45.68
P/E ratio
$0.17
EPS
1.00
Beta
-
Dividend rate
Price and volume
Market cap
$279M
Beta
1
52-week high
$8.90
52-week low
$3.68
Average daily volume
205K
Financial strength
Current ratio
1.831
Quick ratio
0.757
Long term debt to equity
334.025
Total debt to equity
346.465
Interest coverage (TTM)
-0.39%
Management effectiveness
Return on assets (TTM)
-1.94%
Return on equity (TTM)
17.29%
Valuation
Price to earnings (TTM)
45.675
Price to revenue (TTM)
1.805
Price to book
-59.47
Price to tangible book (TTM)
-10.64
Price to free cash flow (TTM)
-26.377
Growth
Revenue change (TTM)
23.42%
Earnings per share change (TTM)
-105.04%
3-year revenue growth (CAGR)
18.32%
3-year earnings per share growth (CAGR)
-46.13%
What the Analysts think about Landec
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Landec stock.
Landec Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Landec Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Landec News
AllArticlesVideos
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation
Accesswire·3 days ago
Lifecore Biomedical: An Interesting CDMO Pure Play
Seeking Alpha·2 weeks ago
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Landec stock?
Landec (LFCR) has a market cap of $279M as of December 14, 2024.
What is the P/E ratio for Landec stock?
The price to earnings (P/E) ratio for Landec (LFCR) stock is 45.68 as of December 14, 2024.
Does Landec stock pay dividends?
No, Landec (LFCR) stock does not pay dividends to its shareholders as of December 14, 2024.
When is the next Landec dividend payment date?
Landec (LFCR) stock does not pay dividends to its shareholders.
What is the beta indicator for Landec?
Landec (LFCR) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.